These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 6916681)
21. A prescription for cutting health care costs. Caring; 1992 Nov; 11(11):10-4. PubMed ID: 10121247 [TBL] [Abstract][Full Text] [Related]
22. Seven therapeutic categories account for most drug cost increases. Manag Care; 2011 Dec; 20(12):69. PubMed ID: 22259880 [No Abstract] [Full Text] [Related]
23. Drugs used in skin outpatient--cost analysis. Prakash B; Singh KG; Kishore N Indian J Public Health; 1988; 32(3):166-7. PubMed ID: 3271763 [No Abstract] [Full Text] [Related]
24. Special report: the value of pharmaceuticals. An "expensive" drug may be the most cost effective. Siegelman S Bus Health; 1991; [VALUE]():8-14. PubMed ID: 10170908 [TBL] [Abstract][Full Text] [Related]
26. The economics of drug prescribing in Ireland. O'Hanrahan M; O'Malley K Ir Med J; 1981 Oct; 74(10):309-10, 312. PubMed ID: 7309452 [No Abstract] [Full Text] [Related]
27. Gap in drug coverage often causes lapses in adherence to drug regimen, study shows. Levenson D Rep Med Guidel Outcomes Res; 2004 Sep; 15(18):9-10, 12. PubMed ID: 15452947 [No Abstract] [Full Text] [Related]
29. Pharmacotherapy: strategies to control drug costs in managed care. Monane M; Nagle B; Kelly MA Geriatrics; 1998 Sep; 53(9):51-4, 63; quiz 64. PubMed ID: 9745626 [TBL] [Abstract][Full Text] [Related]
30. Pharmacoeconomic series: Part I. Pharmacoeconomics and the evaluation of drugs and services. McGhan WF Hosp Formul; 1993 Apr; 28(4):365-6, 371-3, 377-8. PubMed ID: 10125323 [TBL] [Abstract][Full Text] [Related]
31. American Pharmaceutical Association: reinbursement policy for prescription drugs. Apple WS J Am Pharm Assoc; 1974 May; 14(5):236-40. PubMed ID: 4831212 [No Abstract] [Full Text] [Related]
32. The physician's pathway for lower drug costs. Goldberg HC J Fla Med Assoc; 1977 Mar; 64(3):173-5. PubMed ID: 845588 [No Abstract] [Full Text] [Related]
33. Effects of new drugs on overall health spending: Frank Lichtenberg responds. Lichtenberg FR Health Aff (Millwood); 2007; 26(3):887-90. PubMed ID: 17485771 [TBL] [Abstract][Full Text] [Related]
34. Drug cost review--1987. Mehl B Hosp Pharm; 1988 Mar; 23(3):282-3. PubMed ID: 10318046 [No Abstract] [Full Text] [Related]
35. Are generics a drug on the market? Tyler VE J Indiana State Med Assoc; 1980 Jul; 73(7):452-7. PubMed ID: 7452036 [No Abstract] [Full Text] [Related]
36. Position statement: On DHEW proposed rule making on maximum allowable cost for drugs. Challoner DR; Levine RJ Clin Res; 1975 Dec; 23(5):290. PubMed ID: 10325172 [No Abstract] [Full Text] [Related]
37. Pharmacoeconomics: determining the value of drug therapy. Peterson C Healthplan; 1998; 39(3):44-50. PubMed ID: 10181751 [No Abstract] [Full Text] [Related]
38. Retiree health care: a new model for improving health and reducing costs. Erwin WG; Angaran DM Empl Benefits J; 1997 Jun; 22(2):2-4. PubMed ID: 10168419 [TBL] [Abstract][Full Text] [Related]